191 related articles for article (PubMed ID: 32925794)
1. Identification of MTHFD2 as a novel prognosis biomarker in esophageal carcinoma patients based on transcriptomic data and methylation profiling.
Wang J; Luo J; Sun Z; Sun F; Kong Z; Yu J
Medicine (Baltimore); 2020 Sep; 99(37):e22194. PubMed ID: 32925794
[TBL] [Abstract][Full Text] [Related]
2. High Expression of Methylenetetrahydrofolate Dehydrogenase 2 (MTHFD2) in Esophageal Squamous Cell Carcinoma and its Clinical Prognostic Significance.
He H; Li PC; Jia W; Hu B; Ji CS
Med Sci Monit; 2020 Feb; 26():e920259. PubMed ID: 32088725
[TBL] [Abstract][Full Text] [Related]
3. Role of COL3A1 and POSTN on Pathologic Stages of Esophageal Cancer.
Zhang SW; Zhang N; Wang N
Technol Cancer Res Treat; 2020; 19():1533033820977489. PubMed ID: 33280513
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic profiling and mRNA expression reveal candidate genes as biomarkers for colorectal cancer.
Zhang H; Dong S; Feng J
J Cell Biochem; 2019 Jun; 120(6):10767-10776. PubMed ID: 30672027
[TBL] [Abstract][Full Text] [Related]
5. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
Yi L; Luo P; Zhang J
J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
[TBL] [Abstract][Full Text] [Related]
6. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
[TBL] [Abstract][Full Text] [Related]
8. Genome-wide profiling of DNA methylation and gene expression in esophageal squamous cell carcinoma.
Chen C; Peng H; Huang X; Zhao M; Li Z; Yin N; Wang X; Yu F; Yin B; Yuan Y; Lu Q
Oncotarget; 2016 Jan; 7(4):4507-21. PubMed ID: 26683359
[TBL] [Abstract][Full Text] [Related]
9. Identification of Differentially Expressed Genes and miRNAs Associated with Esophageal Squamous Cell Carcinoma by Integrated Analysis of Microarray Data.
Zhang L; Chen J; Cheng T; Yang H; Pan C; Li H
Biomed Res Int; 2020; 2020():1980921. PubMed ID: 32714975
[TBL] [Abstract][Full Text] [Related]
10. Bioinformatics-Based Identification of Methylated-Differentially Expressed Genes and Related Pathways in Gastric Cancer.
Li H; Liu JW; Liu S; Yuan Y; Sun LP
Dig Dis Sci; 2017 Nov; 62(11):3029-3039. PubMed ID: 28914394
[TBL] [Abstract][Full Text] [Related]
11. Bioinformatics-based analysis of the lncRNA-miRNA-mRNA and TF regulatory networks reveals functional genes in esophageal squamous cell carcinoma.
Ye Z; Fang J; Wang Z; Wang L; Li B; Liu T; Wang Y; Hua J; Wang F; Fu Z
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32662828
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive multi-omics analysis identified core molecular processes in esophageal cancer and revealed GNGT2 as a potential prognostic marker.
Liu GM; Ji X; Lu TC; Duan LW; Jia WY; Liu Y; Sun ML; Luo YG
World J Gastroenterol; 2019 Dec; 25(48):6890-6901. PubMed ID: 31908393
[TBL] [Abstract][Full Text] [Related]
13. Clinical significance of circ-MTHFD2 in diagnosis, pathological staging and prognosis of NSCLC.
Geng QQ; Wu QF; Zhang Y; Zhang GJ; Fu JK; Chen NZ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9473-9479. PubMed ID: 33015789
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
15. Identification of Methylation Markers and Differentially Expressed Genes with Prognostic Value in Breast Cancer.
Wu J; Zhang Y; Li M
J Comput Biol; 2019 Dec; 26(12):1394-1408. PubMed ID: 31290690
[TBL] [Abstract][Full Text] [Related]
16. The Identification of Key Genes and Pathways in Glioma by Bioinformatics Analysis.
Liu M; Xu Z; Du Z; Wu B; Jin T; Xu K; Xu L; Li E; Xu H
J Immunol Res; 2017; 2017():1278081. PubMed ID: 29362722
[TBL] [Abstract][Full Text] [Related]
17. MTHFD2 links RNA methylation to metabolic reprogramming in renal cell carcinoma.
Green NH; Galvan DL; Badal SS; Chang BH; LeBleu VS; Long J; Jonasch E; Danesh FR
Oncogene; 2019 Aug; 38(34):6211-6225. PubMed ID: 31289360
[TBL] [Abstract][Full Text] [Related]
18. Detection and characterisation of novel alternative splicing variants of the mitochondrial folate enzyme MTHFD2.
Nicolaidou V; Papaneophytou C; Koufaris C
Mol Biol Rep; 2020 Sep; 47(9):7089-7096. PubMed ID: 32880830
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of MTHFD2 is associated with clinicopathological characteristics and poor survival in ovarian cancer, possibly by regulating MOB1A signaling.
Cui X; Su H; Yang J; Wu X; Huo K; Jing X; Zhang S
J Ovarian Res; 2022 Feb; 15(1):23. PubMed ID: 35135596
[TBL] [Abstract][Full Text] [Related]
20. Development of Multiscale Transcriptional Regulatory Network in Esophageal Cancer Based on Integrated Analysis.
Xu Z; Wu Z; Zhang J; Zhou R; Wu J; Yu B
Biomed Res Int; 2020; 2020():5603958. PubMed ID: 32851080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
